Chief Physician, Associate Professor, Master's Supervisor, Deputy Director of Nephrology, and Head of the CRRT Subspecialty Group
Affiliated HospitalWest China Hospital of Sichuan University
→
-Research areas : complications of hemodialysis, acute kidney injury and critical blood purification technology; CRRT anticoagulation technology.
- Cutting-edge technologies: individualized CRRT dosage for severe cases, early warning model for critical AKI, and the world's first local citrate anticoagulation technology with calcium-containing replacement fluid; comprehensive treatment for severe AKI.
- Areas of expertise: ICU severe acute kidney injury, septic kidney injury, renal replacement therapy for multiple organ dysfunction, chronic nephritis, nephrotic syndrome, diabetic nephropathy, IgA nephropathy, acute kidney injury, hemodialysis.
- Academic Highlights: Leading talent in Sichuan Province's health and wellness sector; member of the Chinese Society of Nephrology; vice chairman of the Chinese Critical Care Blood Purification Collaborative Group; visiting scholar at the Austin Medical Centre, University of Melbourne; published over 200 papers (over 100 SCI papers); recipient of the First Prize of Sichuan Provincial Science and Technology Progress Award and the Second Prize of Huaxia Medical Science and Technology Progress Award; 20 patents, 7 of which have been commercialized. International multicenter AKI collaborative researcher; published high-level papers in journals such as AJKD and CJASN; Core Value: Constructed a domestic risk prediction model for severe AKI and promoted standardized CRRT clinical implementation guidelines.